Morten K. Lindhardt
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Nudges for Guideline-Directed Medical Therapy in Chronic Kidney Disease: Long-Term Follow-Up of the NUDGE-CKD Trial.
Journal: Journal of the American College of Cardiology
Published: January 29, 2026
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW.
Journal: Cardiovascular diabetology
Published: August 29, 2025
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease.
Journal: Cardiovascular diabetology
Published: June 11, 2025
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre study.
Journal: Diabetes, obesity & metabolism
Published: May 09, 2025
Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart study.
Journal: Cardiovascular diabetology
Published: February 10, 2025
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease.
Journal: American heart journal
Published: January 19, 2025
Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study.
Journal: Diabetologia
Published: November 19, 2024
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.
Journal: Diabetes, obesity & metabolism
Published: July 23, 2024
Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study.
Journal: BMC primary care
Published: May 08, 2024
Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death.
Journal: Journal of hypertension
Published: December 18, 2023
Last Updated: 09/26/2026